Evidence map›Paper›PMID 42875414›Full record

ArticleNature communications2026

Telomere length of both parents contributes to heritable POT1 cancer-predisposition syndrome.

Annika Martin, Robert Lu, Alise Blake, Kim E Nichols, Santiago E Sanchez, Steven E Artandi, Sharon A Savage, Richa Sharma, Dirk Hockemeyer

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Annika Martin *Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0009-0006-3369-1495
Robert Lu *Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
Alise BlakeDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Kim E NicholsDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-5581-6555
Santiago E SanchezStanford Cancer Institute, Stanford University, Stanford, CA, USA.
Steven E ArtandiMedical Scientist Training Program, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-5580-7512
Sharon A SavageClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-6006-0740
Richa SharmaDepartment of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic Children's, Cleveland, OH, USA.
Dirk HockemeyerDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. hockemeyer@berkeley.edu.ORCID http://orcid.org/0000-0002-5598-5092

Funding

American Cancer Society (American Cancer Society, Inc.) 133396-RSG-19-029-01-DMCU.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL131744-05
6 · The paper itself

Abstract

Germline and somatic mutations in POT1 promote oncogenesis by enabling aberrant telomere elongation. For inherited POT1 mutations, it remains unclear whether elongated telomeres are transmitted to the next generation and whether the inherited long telomeres elevate cancer risk. Using a nanopore sequencing approach that provides haplotype-specific telomere length resolution, we examined telomere inheritance in families carrying POT1 mutations. We found that offspring preferentially inherit their longest telomeres from the carrier parent, consistent with extensive germline telomere elongation, whereas comparatively short telomeres predominantly derive from the non-carrier parent. Analysis of carrier and non-carrier siblings demonstrated that telomeres from both parents are elongated in POT1 carriers, with preferential elongation of the shortest telomeres. These findings support a potential mechanism of genetic anticipation in which POT1 mutations progressively deplete short telomeres capable of enforcing telomere-based tumor suppression from the carrier germline. Therefore, telomeres inherited from both parents jointly shape telomere-based tumor suppressive barriers.

Indexed as

Genetic Predisposition to DiseaseNeoplasmsTelomereTelomere-Binding ProteinsTelomere HomeostasisFemaleGerm-Line MutationHaplotypesHumansMaleMutationShelterin ComplexPOT1 protein, humanShelterin ComplexTelomere-Binding Proteins

Identifiers

PMID42875414
PMCPMC13669393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.